Sulphatide binds to human and animal influenza A viruses, and inhibits the viral infection

被引:86
作者
Suzuki, T
Sometani, A
Yamazaki, Y
Horiike, G
Mizutani, Y
Masuda, H
Yamada, M
Tahara, H
Xu, GY
Miyamoto, D
Oku, N
Okada, S
Kiso, M
Hasegawa, A
Ito, T
Kawaoka, Y
Suzuki, Y
机构
[1] UNIV SHIZUOKA, SCH PHARMACEUT SCI, DEPT BIOCHEM, SHIZUOKA 422, JAPAN
[2] UNIV SHIZUOKA, SCH PHARMACEUT SCI, DEPT RADIOBIOCHEM, SHIZUOKA 422, JAPAN
[3] GIFU UNIV, DEPT APPL BIOORGAN CHEM, GIFU 50111, JAPAN
[4] ST JUDE CHILDRENS RES HOSP, DEPT VIROL & MOL BIOL, MEMPHIS, TN 38101 USA
关键词
D O I
10.1042/bj3180389
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We found, by using a virus overlay assay, that influenza A virus isolates bind to sulphatide (HSO3-Gal beta 1 --> 1'Cer), which has no sialic acid residue, and that the infection of Madin-Darby canine kidney cells with the human influenza virus A/Memphis/1/71 (H3N2) is inhibited by sulphatide. A/Memphis/1/71 (H3N2) causes obvious haemagglutination and low-pH haemolysis of asialoerythrocytes reconstituted with sulphatide. All influenza A virus isolates from the species of animals so far tested bound to sulphatide. The sulphatide-binding specificity of the isolates was different from the viral sialyl-linkage specificity. Influenza A virus isolates also bound to galactosyl ceramide (GalCer; Gal beta 1 --> 1'Cer), as well as sulphatide, in the virus overlay assays. In contrast. the influenza virus did not bind to N-deacyl, a derivative of sulphatide, glucosyl ceramide or the other neutral glycolipids tested. These results indicate that the linkage of galactose, or sulphated galactose, to ceramide is important for viral binding.
引用
收藏
页码:389 / 393
页数:5
相关论文
共 30 条
[1]  
ALLAIN CC, 1973, CLIN CHEM, V19, P223
[2]   GALACTOSYL CERAMIDE OR A DERIVATIVE IS AN ESSENTIAL COMPONENT OF THE NEURAL RECEPTOR FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN GP120 [J].
BHAT, S ;
SPITALNIK, SL ;
GONZALEZSCARANO, F ;
SILBERBERG, DH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (16) :7131-7134
[3]   ERYTHROCYTE-P ANTIGEN - CELLULAR RECEPTOR FOR B19 PARVOVIRUS [J].
BROWN, KE ;
ANDERSON, SM ;
YOUNG, NS .
SCIENCE, 1993, 262 (5130) :114-117
[4]  
CARROLL SM, 1981, J BIOL CHEM, V256, P8357
[5]  
CHIEN JL, 1979, J LIPID RES, V20, P669
[6]  
CLARKE JTR, 1971, J BIOL CHEM, V246, P5563
[7]   RECEPTOR SPECIFICITY IN HUMAN, AVIAN, AND EQUINE H2 AND H3 INFLUENZA-VIRUS ISOLATES [J].
CONNOR, RJ ;
KAWAOKA, Y ;
WEBSTER, RG ;
PAULSON, JC .
VIROLOGY, 1994, 205 (01) :17-23
[8]   INFECTION OF COLONIC EPITHELIAL-CELL LINES BY TYPE-1 HUMAN-IMMUNODEFICIENCY-VIRUS IS ASSOCIATED WITH CELL-SURFACE EXPRESSION OF GALACTOSYLCERAMIDE, A POTENTIAL ALTERNATIVE GP120 RECEPTOR [J].
FANTINI, J ;
COOK, DG ;
NATHANSON, N ;
SPITALNIK, SL ;
GONZALEZSCARANO, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) :2700-2704
[9]  
HAATAJA S, 1993, J BIOL CHEM, V268, P4311
[10]   SYNTHETIC STUDIES ON SIALOGLYCOCONJUGATES .23. TOTAL SYNTHESIS OF SIALYL-ALPHA(2-]6)-LACTOTETRAOSYLCERAMIDE AND SIALYL-ALPHA(2-]6)-NEOLACTOTETRAOSYLCERAMIDE [J].
HASEGAWA, A ;
HOTTA, K ;
KAMEYAMA, A ;
ISHIDA, H ;
KISO, M .
JOURNAL OF CARBOHYDRATE CHEMISTRY, 1991, 10 (03) :439-459